Related Experiment Videos
Restenosis 3 months after successful percutaneous aortic valvoplasty. A clinicopathological report
P W Serruys1, C Di Mario, C E Essed
1Thoraxcenter, Erasmus University, Rotterdam, The Netherlands.
Insights
Aortic stenosis recurrence after valvoplasty may be linked to scarring. Histology revealed scarring near calcification, suggesting a role in restenosis after aortic valve procedures.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pathology
Background:
- Severe, calcific aortic stenosis poses significant risks.
- Percutaneous aortic valvoplasty is a treatment option for aortic stenosis.
Observation:
- A 76-year-old man with severe aortic stenosis experienced symptom recurrence 3 months post-percutaneous aortic valvoplasty.
- Echocardiography revealed a significant increase in peak aortic flow velocity post-procedure.
Findings:
- Histological examination adjacent to fragmented calcification showed a scarring reaction.
- This scarring may be a primary factor contributing to restenosis.
Implications:
- Understanding restenosis mechanisms is crucial for improving valvular interventions.
- Scarring reactions warrant further investigation in the context of aortic valve procedures.
Abstract:
A 76-year-old man with severe, calcific aortic stenosis experienced recurrence of symptoms 3 months after a successful percutaneous aortic valvoplasty. Echo Doppler revealed a marked increase of peak aortic flow velocity as compared with the immediate post-valvoplasty value. The patient underwent an uncomplicated aortic valve replacement. Adjacent to fragmented calcification, histology demonstrated a scarring reaction which might well be a major factor in the restenosis process.